Cigna Corporation logo CI - Cigna Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 1
BUY 29
HOLD 9
SELL 0
STRONG
SELL 0
| PRICE TARGET: $340.17 DETAILS
HIGH: $400.00
LOW: $302.00
MEDIAN: $335.00
CONSENSUS: $340.17
UPSIDE: 18.84%

Stock News

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may as well. All of the major indices finished Tuesday lower, and with Q1 earnings all but over and the incoming economic data... Here Are Wednesday's Top Wall Street Analyst Research Calls: BJ's Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

May 20, 2026 03:59 AM • 247wallst.com
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (May 2026)

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (May 2026)

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.74%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

May 02, 2026 04:00 AM • seekingalpha.com
Cigna Q1 Earnings Support A Higher Valuation

Cigna Q1 Earnings Support A Higher Valuation

Cigna Group (CI) delivers robust quarterly results, with adjusted EPS up 16% and revenue up 5%, reinforcing core business resilience. CI raises 2026 adjusted EPS outlook to at least $30.35, reflecting confidence in margin expansion and ongoing shareholder returns via buybacks and dividends. Valuation remains compelling at 9.6x forward earnings, with strong cash flow, disciplined capital deployment, and a solid balance sheet supporting the Buy rating.

May 01, 2026 06:12 AM • seekingalpha.com

Price Targets